期刊文献+

番茄红素对血液透析患者静脉铁剂诱导氧化应激的影响 被引量:6

Effects of Lycopene on Oxidative Stress Induced by Intravenous Iron in Maintenance Hemodialysis Patients
在线阅读 下载PDF
导出
摘要 目的:观察维持性血液透析(MHD)患者由静脉铁剂诱导的氧化应激状态,探讨番茄红素对其的干预作用。方法:30例MHD患者,随机分为对照组和试验组,各15例。对照组在患者透析时给予蔗糖铁注射液100 mg,2次/周,共10次,观察时间8周;试验组除蔗糖铁注射液使用外,同时口服番茄红素胶囊,2粒/次,2次/d。用药8周,观察时间8周,观察并比较两组患者治疗前及治疗8周后的血红蛋白(Hb)、红细胞比容(Hct)、血清铁(SI)、铁蛋白(SF)、转铁蛋白饱和度(TSAT)以及超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-px)、丙二醛(MDA)等指标的变化。结果:两组患者治疗后SOD和GSH-px水平较治疗前均有显著下降(P<0.01);但是试验组下降幅度显著性小于对照组(P<0.01)。两组患者治疗后MDA水平较治疗前有显著性升高(P<0.01);但是试验组升高幅度显著性小于对照组(P<0.01)。治疗后两组血清MDA水平与SF呈正相关(P<0.01)。治疗后两组Hb、Hct、SI、SF、TSAT较治疗前均有显著性升高(P<0.01),并且两组升高幅度相似,无统计学差异。结论:静脉铁剂治疗加剧了MHD患者的氧化应激状态。番茄红素可减轻这种氧化应激状态。 Objective:To observe oxidative stress induced by intravenous iron and its prevention by lycopene in maintenance hemodialysis(MHD) patients. Methods:30 MHD patients were randomly divided into two groups:control group( n = 15) and treatment group(n = 15). In control group, the patients were treated with iron sucrose 100rag intravenously, during 10 consecutive hemodialysis sessions,twice a week for five weeks. In treatment group, in addition to intravenous iron, the patients were given lycopene, 2 # orally, twice a day for eight weeks. Their hemoglobin ( lib ), hematocrit ( Hct ), serum iron(SI), serum ferritin(SF), trans- ferring saturation(TAST) ,superoxide disrnutase (SOD), glutathione peroxidase ( GSH - px) and malondialdehyde (MDA) levels were measured at pre- and post- treatment. Results:Compared with those in the pre- treatment,the levels of serum SOD and GSH - px in both groups decreased markedly(P〈0.01), but the descent range of serum SOD and GSH- px in treatment group was less than those in control group(P〈0.01).Compared with those at the pre- treatment,the levels of serum MDA in both groups were elevated significantly( P 〈 0.01 ). but the increarnent rate of MDA in treatment group was less than that in control group( P 〈 0.01 ). At post - treatment, the levels of serum MDA were positively correlated to the levels of SF in both groups ( P 〈 0.01 ). Compared with those in the pre - treatment, the levels of lib, Hct, SI, SF, and TSAT increased significantly in both groups( P 〈 0.01 ) at post - treatment. Moreover, the increarnent rates of them were not significantly different between both of groups. Conclusion: Intravenous iron therapy could induce aggravation of oxidative stress in MHD patients, which could be alleviated by lycopene.
出处 《中国中西医结合肾病杂志》 2008年第5期423-425,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 番茄红素 氧化应激 静脉铁剂 血液透析 Lycopene Oxidative stress Intravenous iron Hemodialysis
  • 相关文献

参考文献7

  • 1Fishbane S,Frei GL,Maesaka J.Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis,1995,26(1):41-46.
  • 2Reis KA,Guz G,Ozdemir H,et al.Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease.Int Heart J,2005,46(2):255-264.
  • 3Di Mascio P,Kaiser S,Sies H.Lycopene as the most efficient biological carotenoid singlet oxygen quencher.Arch Biochem Biophys,1998,274(2):532-538.
  • 4Klipstein GK,Launer LJ,Geleijnse JM,et al.Serum carotenoids and atherosclerosis. The Rotterdam Study.Atherosclerosis,2000,148(1):49-56.
  • 5Rissanen TH,Voutilainen S,Nyyssonen K,et al.Serum lycopene concentrations and carotid atherosclerosis: the kuopio ischaemic heart disease risk factor study.Am J Clin Nutr,2003,77(1):133-138.
  • 6唐湘宇,孙文清,王蕾,郭芳,何慧,丁莉,屈顺林,肖纯,杨向东.番茄红素对高脂兔血管脂质过氧化损伤的影响及机制探讨[J].中国临床药理学与治疗学,2006,11(2):158-163. 被引量:16
  • 7Barnes PJ,Karin M.Nuclear factor-kappa B:A pivotal transcription factor in chronic inflammatory diseases.N Engl J Med,1997,336(15):1066-1071.

二级参考文献13

  • 1Stringer MD,Gorog PG,Freeman A,KakkarVV.Lipid peroxides and atherosclerosis[J].Br Med J,1989;298:281-3
  • 2Klipstein Grobusch K,Launer LJ,geleijnse JM,Boeing H,Hofman A,Witteman JC.Serum carotenoids and atherosclerosis.The Rotterdam Study[J].Atherosclerosis,2000;148:49-56
  • 3Rissanen TH,Voutilainen S,Nyyssonen K,Salonen R,Kaplan GA,Salonen JT.Serum lycopene concentrations and carotid atherosclerosis:the Kuopis Ischaemic Heart Disease Risk Factor Study[J].Am J Clin Nutr,2003;77:133-8
  • 4Tiina R,Sari V,Kristiina N,Jukka T.Salonen Lycopene,Atherosclerosis,and Coronary Heart Disease[J].Exp Biol Med,2002;227:900-7
  • 5Wick G,Perschinka H,Xu Q.Autoimmunity and atherosclerosis[J].Am Heart J,1999;138:S444-9
  • 6Miyata K,Shimokawa H,Yamawaki T,Kunihiro I,Zhou X,Higo T.Endothelial vasodilaor function is preserved at the spastic/inflammatory coronary lesions in pigs[J].Circulation,1999;100:1432-7
  • 7Marco ND,Balz F,Joseph A.Vita and John F.Keaney,Antioxidants and Atherosclerotic Heart Disease[J].N Engl J Med,1997;337:408-16
  • 8Mortensen A,Skibsted LH,Sampson J,Rice-Evans C,Everett SA.Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants[J].FEBS Lett,1997;418:91-7
  • 9Paolo DM,Devasagayam TPA.Carotenoids,tocopherols and thiols as biological single molecular oxygen quenchers[J].Biochem Soc Trans,1990;18:1054-6
  • 10Rao AV,Agarwal S.Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer[J].Nutr Cancer,1998;31:199-203

共引文献15

同被引文献53

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部